NCT05347095FUZIONperianal fistulizing Crohn’s diseaseGUSmethotrexateperianal fistulizing CD6-mercaptopurineGuselkumabazathioprine
…for moderately-to-severely active CD, was evaluated in FUZION ( NCT05347095), an ongoing Phase 3, randomized, placebo-controlled, double-bl…